American Journal of Nephrology
Author Guidelines
About the Journal
Aims and Scope
The American Journal of Nephrology is a peer-reviewed journal that focuses on timely topics in both basic science and clinical research. Papers are divided into several sections, including: original reports, spanning clinical, basic, and outcomes research; in-depth topic reviews on specific topics selected by the editor and associate editors; invited debates, selected on “hot topics” determined by the editorial board. Responding to the ever-increasing pace in research, the American Journal of Nephrology adheres to a very tight publication schedule: accepted papers appear online within 5–6 weeks of acceptance.
Journal Sections
Original Reports
- Transplantation: Manuscripts under this section include both basic and translational topics. Original experimental data are preferred; however, other content will be considered.
- Patient-oriented, Translational Research
- Laboratory Investigations
In-Depth Topic Reviews
All In-Depth Topic Reviews agreed upon by the senior editors are invited. If an individual or group has an idea for an in depth review topic, they should email an outline in a word document to the managing editor (bbrisky@medicine.bsd.uchicago.edu) prior to writing the review.
PLEASE NOTE: this outline should not be submitted through the journal system. This document should include 1) relevance of review; 2) proposed authors with their institution and areas of expertise; and 3) outline of review headings. The topic will be discussed by senior editors and a decision regarding acceptability reached within 2-3 weeks. If the topic and approach are acceptable, the authors will be granted permission to proceed with submission of the full review through the online system. NOTE: permission to proceed does NOT assure acceptance of the final review article. An Abstract is required and should be divided into Background, Summary and Key Messages. Review papers will be published free of page charges.
Novel Research Findings
The focus of these papers is to highlight novel findings as a part of a larger, more comprehensive study. These findings need to be both innovative and potentially helpful to other researchers without compromising the subsequent publication of the author’s primary study. The data can focus on mechanisms related to disease or aspects of clinical management that might extend knowledge and facilitate the research of other investigators. Papers should be maximum 2500 words and 15 references with one figure and Table maximum. They should have an abstract of 150 words maximum in the same format as original articles as well.
Invited Editorials
The Editor(s) will invite editorials on specifically selected articles. The editorial will have a maximum of 1,000 words and up to 7 references (one of which should be the paper being reviewed). The title of the article which the Invited Editorial is being based on should be included on the Title Page.
Invited Perspective
This section is devoted to challenges to either evidence based opinion of either existing ideas or new ideas based on a strong hypothesis with some preliminary evidence. The letter cannot be longer than 2000 words and should contain no more than 20 references. Maximum one figure or table is allowed. No Abstract is required.
Article Types
Research Article
Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.
Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.
Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.
A downloadable template is available below.
Documents
Research Article (DOCX, 28.97 KB)
Research articles should be no more than 5,000 words, including references and a maximum of 4 tables and/or figures.
Review Article
Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
A downloadable template is available below.
Documents
Review Article (DOCX, 23.66 KB)
Review articles should be no more than 6,000 words, including references and a maximum of 4 tables and/or figures.
Commentary
Commentaries draw attention to a jointly published article, discussing the context or implications of the article and highlighting points of wider relevance to the field. Commentaries are presented from the author’s perspective and do not include original data. Commentaries are invited by the Editors and relate to an article in the same issue.
A downloadable template is available below.
Documents
Commentary (DOCX, 23.56 KB)
Editorial
Editorials provide a viewpoint on specific articles or on general subjects directly relevant to the journal. Editorials are written by an editor or other member of the journal.
A downloadable template is available below.
Documents
Editorial (DOCX, 24.95 KB)
Editorials should be no more than 1,000 words, with up to 7 references and a maximum of 1 table or figure.
Letter
Letters may explore subjects related to matters discussed in the journal, providing the author’s perspective on a subject. Letters may discuss a recently published article and may lend support or constructively critique the article in line with the author’s experience. The editors reserve the right to share such letters to the authors of the article concerned prior to publication in order to permit response, ideally in the same issue of the journal. Letters should not include original data.
A downloadable template is available below.
Documents
Letter (DOCX, 24.24 KB)
Letters submitted to the "Invited Perspective" section should be no longer than 2000 words and contain no more than 20 references. Maximum one figure or table is allowed. No Abstract is required.
Contact Information
Should you have any problems with your submission, please contact the editorial office:
Barbara Brisky
bbrisky@medicine.bsd.uchicago.edu
Fax: +1 773.834.0486
Editorial and Journal Policies
General Conditions
Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.
All manuscripts are subject to editorial review.
The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).
Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.
By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author.
Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement.
Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/. Another widely used licensing tool is PLSClear. Please check the publishers’ websites for the available options and user instructions.
Statements
All submitted manuscripts must contain a statements section after the main body of the text, but before the reference list.
Statement of Ethics
Published research must comply with internationally-accepted standards for research practice and reporting. Manuscripts may be rejected if the editors believe that the research has not been carried out within an appropriate ethical framework, and concerns raised after publication may lead to a correction, retraction, or expression of concern in line with COPE guidelines.
Studies involving human subjects (including research on identifiable human material and data) must have been performed with the approval of an appropriate ethics committee and with appropriate participants’ informed consent in compliance with the Helsinki Declaration.
In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate. If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision).
For all research involving human subjects, written informed consent to participate in the study should be obtained from participants (or their parent/legal guardian where appropriate ) and a statement detailing this should appear in the manuscript. For studies involving vulnerable participants or participants at risk of potential coercion, detailed information regarding the steps taken to ensure informed consent must be provided. If consent was not obtained, please specify why and whether this was approved by the ethics committee.
In line with the ICMJE recommendations on the protection of research participants, authors must avoid providing identifying information unless strictly necessary for the submission and participants’ identifiable attributes must be anonymized in the manuscript and its supplementary files, if any. If identifying information is necessary, authors must confirm that the individual has provided written consent for the use of that information in a publication.
……
更多详情：
https://www.karger.com/Journal/Guidelines/223979
